Navigation
Policy Briefs & Issue Papers
IPPI scholars play an active role in the intellectual property policy debate, writing numerous policy briefs and issue papers about intellectual property rights and the technological, commercial, and creative innovation they facilitate.
Below are some selected highlights.
Recent Highlights
- Kristen Jakobsen Osenga, Fact Sheet: Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive (RESTORE) Patent Rights Act of 2025 (IPPI Nov. 2025) | Description: Although the Constitution sets forth a patent as an exclusive right, the U.S. Supreme Court decided nearly twenty years ago that the right to exclude can be denied in favor of a royalty payment. Professor Kristen Osenga, IPPI’s Senior Fellow for Innovation Policy & a Senior Scholar, has written a fact sheet on the RESTORE Bill, which is Congress’s attempt to restore the exclusive rights to patent owners as intended by the Constitution.
- Kristen Jakobsen Osenga, Fact Sheet: Patent Eligibility Restoration Act of 2025 (PERA) (IPPI Oct. 2025) | Description: Over a decade ago, a series of Supreme Court decisions created uncertainty around patent eligibility, particularly with regard to diagnostics and computer-related inventions. This created a number of perhaps unintended consequences, which Congress now has a chance to resolve with the Patent Eligibility Act of 2025 (PERA). In a new IPPI fact sheet, Professor Kristen Jakobsen Osenga explains PERA, what problems it solves, and why it is important for innovation and investment.
- William Matcham et al, Measuring Patent Quality and Reducing the Backlog at the USPTO (IPPI Jul. 2025) [Fact Sheet: “Evidence on U.S. Patent Quality and Reforms to Reduce Patent Application Backlogs“] | Description: There has been a lot of discussion about both patent quality and the current backlog, along with possible ways to improve one or the other. This policy brief presents recent empirical findings on patent quality, highlights the limitations of certain metrics as a measure of patent quality, and proposes viable reforms aimed at reducing application backlogs while maintaining high patent quality.
- Ani Harutyunyan, Matthew Chervenak, Mark Schankerman, William Matcham*, & Nishant Shrestha, Patent Quality in the United States: Findings and Suggestions for Policymakers, Sunwater Institute (September 2024) | * Dr. Ani Harutyunyan and Dr. William Matcham were 2022-2023 Edison Fellows. Dr. Matcham is an IPPI Scholar.
- Kristina M.L. Acri née Lybecker, The Importance of Injunctive Relief and the RESTORE Patent Rights Act (IPPI Mar. 2025; original publication: Ctr. for Intell. Prop. x Innov. Pol. Blog Nov. 2024 [archived version]) | Description: In this policy brief, IPPI Senior Scholar Kristina M.L. Acri née Lybecker (Professor of Economics and Business, Colorado College) looks at the challenges introduced to the U.S. patent system by eBay Inc. v. MercExchange LLC and how the RESTORE Patent Rights Act could “reestablish a rebuttable presumption of an injunction in favor of patent owners who prove their patents have been infringed. This would place the burden on the infringer to demonstrate that a permanent injunction is not warranted, eliminating the perverse incentives that encourage predatory infringement and encouraging preinfringement licensing negotiations.”
- Kristen Jakobsen Osenga, Restoring Predictability to Patent Eligibility (IPPI Mar. 2025; original publication: Ctr. for Intell. Prop. x Innov. Pol. Blog Apr. 2024 [archived version]) | Description: In this policy brief, Senior Fellow for Innovation Policy and Senior Scholar Kristen Jakobsen Osenga (Associate Dean for Academic Affairs, Austin E. Owen Research Scholar & Professor of Law, University of Richmond School of Law) looks at how, “[b]y restoring a level of predictability to patent eligibility, PERA will encourage firms to continue their cutting-edge inventive and innovative activities in the United States.”
- Saurabh Vishnubhakat, Toward the Substitutionary Promise of PTAB Review (IPPI Mar. 2025; original publication: Ctr. for Intell. Prop. x Innov. Pol. Apr. 2024 [archived version]) | Description: In this policy brief, Professor Saurabh Vishnubhakat (Benjamin N. Cardozo School of Law) looks at how the proposed PREVAIL Act “contains reforms that address . . . [three] significant problems and are therefore especially welcome steps toward fulfilling the original aims of the America Invents Act.”
- Eric M. Solovy, The TRIPS Waiver for COVID-19 Vaccines, and Its Potential Expansion: Assessing the Impact on Global IP Protection and Public Health (Ctr. for Intell. Prop. x Innov. Pol. Dec. 2022) | Description: In this policy brief, Eric M. Solovy looks at the impact the TRIPS waiver has had so far and potential impacts of the proposed expansion to the waiver.
- Eric M. Solovy and Deepak Raju, Recent Threats to Global Trade Secret Protection: Why Compulsory Licensing Is Not (and Should Not Be) a Viable Legal Option (Ctr. for Intell. Prot. x Innov. Pol. Oct. 2021) | Description: In this Policy Brief, Eric M. Solovy and Deepak Raju look at the international and domestic law of trade secret protection and the potential for compulsory licensing of this type of IP right. In the wake of the COVID-19 pandemic, there has been increased discussion about waiving IP rights, including trade secrets, in an attempt to speed access to vaccines and other medicines. Mr. Solovy and Mr. Raju discuss the purpose and importance of trade secret protection, and why compulsory licensing of undisclosed information protected as trade secrets is not possible under current international and domestic laws.
- Matthew Jordan, Neil Davey, Maheshkumar P. Joshi, & Raj Davé, Forty Years Since Diamond v. Chakrabarty: Legal Underpinnings and its Impact on the Biotechnology Industry and Society (Ctr. for the Prot. of Intell. Prop. Jan. 2021) | Description: This policy brief celebrates the fortieth anniversary of the Diamond v. Chakrabarty decision, where the Supreme Court in 1980 held that a genetically modified bacteria was patentable subject matter. The brief, entitled Forty Years Since Diamond v. Chakrabarty: Legal Underpinnings and its Impact on the Biotechnology Industry and Society and written by Matthew Jordan, Neil Davey, Maheshkumar P. Joshi, and Raj Davé, is dedicated to the late Dr. Ananda Chakrabarty, a pioneer in the biotechnology world, who passed away in July 2020. Chakrabarty had a great impact on the biotechnology revolution, ushering in a new era of technological advances that have benefited humankind. Through interviews with Randall Rader, former Chief Judge of the Federal Circuit, and Dr. Chakrabarty himself, as well as case studies on genetically modified seeds, polymerase chain reactions, and monoclonal antibody therapies, the policy brief explores the importance and enduring implications for society of the Chakrabarty decision.
- Joanna M. Shepherd, The Legal and Industry Framework of Pharmaceutical Product Hopping and Considerations for Future Legislation (Ctr. for the Prot. of Intell. Prop. Dec. 2020) | Description: In this policy brief, Joanna Shepherd, Vice Dean and Thomas Simmons Professor of Law at Emory University School of Law, discusses the practice of so-called “product hopping,” where a pharmaceutical company turns its focus to newer versions of its existing drugs. Prof. Shepherd explains that the product hopping phenomenon is incentivized by the legal and industry framework in which pharmaceutical companies operate. She looks at the existing case law on whether the practice violates antitrust law to find points of agreement, and she uses that synthesis to suggest considerations for future legislative efforts to balance the needs of consumers and producers. Finally, Prof. Shepherd warns that any legislation aimed at product hopping should be cautious so as not to ultimately harm consumers, reduce innovation, and increase health care spending.
- Jonathan M. Barnett, The Long Shadow of the Blackberry Shutdown That Wasn’t (Ctr. for the Prot. of Intell. Prop. July 2020) | Description: This policy brief by former CPIP Senior Fellow for Innovation Policy Jonathan Barnett looks at how the Blackberry litigation and the “patent troll” narrative ultimately contributed to the Supreme Court’s 2006 decision in eBay v. MercExchange that limited the availability of injunctive relief for successful patentees. Prof. Barnett then examines the problematic legacy of the post-eBay case law, which significantly shifted the legal infrastructure supporting the U.S. innovation markets. In particular, he explains how this shift has led to opportunistic infringement that favors downstream incumbents with the resources to fund extensive litigation at the expense of upstream innovators—a dynamic that is exemplified in the recent litigation between Sonos and Google.
- Jonathan M. Barnett, The End of Patent Groupthink (Ctr. for the Prot. of Intell. Prop. Apr. 2020) | Description: In this policy brief, former CPIP Senior Fellow for Innovation Policy Jonathan Barnett highlights some cracks that have emerged in the recent policy consensus that the U.S. patent system is “broken” and it is necessary to “fix” it. Policymakers have long operated on the basis of mostly unquestioned assumptions about the supposed explosion of low quality patents and the concomitant patent litigation that purportedly threaten the foundation of the innovation ecosystem. These assumptions have led to real-world policy actions that have weakened patent rights. But as Prof. Barnett discusses in the policy brief, that “groupthink” is now eroding as empirical evidence shows that the rhetoric doesn’t quite match up to the reality. This has translated into incremental but significant movements away from the patent-skeptical trajectory that has prevailed at the Supreme Court, the USPTO, and the federal antitrust agencies.
Policy Briefs & Issue Papers A to Z
- Kristina M.L. Acri née Lybecker, The Importance of Injunctive Relief and the RESTORE Patent Rights Act (Ctr. for Intell. Prop. x Innov. Pol. Nov. 2024)
- Sandra Aistars, Devlin Hartline, & Mark Schultz, Copyright Principles and Priorities to Foster a Creative Digital Marketplace (Ctr. for the Prot. of Intell. Prop. Dec. 2015)
- Jonathan M. Barnett, The End of Patent Groupthink (Ctr. for the Prot. of Intell. Prop. Apr. 2020)
- Jonathan M. Barnett, The Long Shadow of the Blackberry Shutdown That Wasn’t (Ctr. for the Prot. of Intell. Prop. July 2020)
- Bruce Boyden, The Failure of the DMCA Notice and Takedown System: A Twentieth Century Solution to a Twenty-First Century Problem (Ctr. for the Prot. of Intell. Prop. Dec. 2013)
- Ross E. Davies, Ebb and Flow in Safe Harbors: Some Exemplary Experiences Under One Old Statute and One New (Ctr. for the Prot. of Intell. Prop. Sept. 2020)
- Greg Dolin, The Costs of Patent “Reform”: The Abuse of the PTO’s Administrative Review Programs (Ctr. for the Prot. of Intell. Prop. Dec. 2014)
- Greg Dolin, Resolving the Patent-Antitrust Paradox: Promoting Consumer Welfare Through Innovation (Ctr. for the Prot. of Intell. Prop. May 2013)
- Richard A. Epstein, Curbing the Abuses of China’s Anti-Monopoly Law: An Indictment and Reform Agenda (Ctr. for the Prot. of Intell. Prop. Dec. 2014)
- Richard A. Epstein, The Dangerous Adventurism of the United States Trade Representative: Lifting The Ban Against Apple Products Unnecessarily Opens A Can Of Worms In Patent Law (Ctr. for the Prot. of Intell. Prop. Aug. 2013)
- Devlin Hartline & Matthew Barblan, Debunking the Royalty Stacking Theory: Real-World Evidence From the Mobile Wireless Industry (Ctr. for the Prot. of Intell. Prop. Jan. 2016)
- Devlin Hartline & Matthew Barblan, Protecting Authors and Artists by Closing the Streaming Loophole (Ctr. for the Prot. of Intell. Prop. Oct. 2015)
- Ani Harutyunyan, Matthew Chervenak, Mark Schankerman, William Matcham, & Nishant Shrestha, Patent Quality in the United States: Findings and Suggestions for Policymakers (Sunwater Institute 2024)
- Ani Harutyunyan & William Matcham, Fact Sheet: “Evidence on U.S. Patent Quality and Reforms to Reduce Patent Application Backlogs” (IPPI Jul. 2014)
- Ani Harutyunyan & William Matcham, Measuring Patent Quality and Reducing the Backlog at the USPTO (IPPI Jul. 2014)
- Christopher M. Holman, The Critical Role of Patents in the Development, Commercialization, and Utilization of Innovative Genetic Diagnostic Tests (Ctr. for the Prot. of Intell. Prop. July 2014)
- Christopher M. Holman, An Unwise Move to Discriminate Against Pharmaceutical Patents: Responding to the UN’s Guidelines for Pharmaceutical Patent Examination (Ctr. for the Prot. of Intell. Prop. June 2018)
- Matthew Jordan, Neil Davey, Maheshkumar P. Joshi, & Raj Davé, Forty Years Since Diamond v. Chakrabarty: Legal Underpinnings and its Impact on the Biotechnology Industry and Society (Ctr. for the Prot. of Intell. Prop. Jan. 2021)
- Keith Mallinson, Busting Smartphone Patent Licensing Myths (Ctr. for the Prot. of Intell. Prop. Sept. 2015)
- Amanda Maxham, The Gene Revolution (Ctr. for the Prot. of Intell. Prop. Nov. 2015)
- Kristen Jakobsen Osenga, Fact Sheet: Patent Eligibility Restoration Act of 2025 (PERA) (IPPI Oct. 2025)
- Kristen Jakobsen Osenga, Fact Sheet: Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive (RESTORE) Patent Rights Act of 2025 (IPPI Nov. 2025)
- Kristen Jakobsen Osenga, Restoring Predictability to Patent Eligibility (Ctr. for Intell. Prop. x Innov. Pol. Apr. 2024)
- Kristen Osenga, Saving Functional Claiming: The Mismatch of § 112 Reform in the § 101 Reform Debate (Hudson Inst. Jan. 2020)
- Mark Schultz, Stephen Ezell, & David Lund (eds.), Innovate4Health: How Innovators Are Solving Global Health Challenges (Ctr. for the Prot. of Intell. Prop. Apr. 2018)
- Mark Schultz & Kevin Madigan, The Long Wait for Innovation: The Global Patent Pendency Problem (Ctr. for the Prot. of Intell. Prop. Oct. 2016)
- Joanna M. Shepherd, The Legal and Industry Framework of Pharmaceutical Product Hopping and Considerations for Future Legislation (Ctr. for the Prot. of Intell. Prop. Dec. 2020)
- Eric M. Solovy and Deepak Raju, Recent Threats to Global Trade Secret Protection: Why Compulsory Licensing Is Not (and Should Not Be) a Viable Legal Option (Ctr. for Intell. Prop. x Innov. Pol. Oct. 2021)
- Eric M. Solovy, The TRIPS Waiver for COVID-19 Vaccines, and Its Potential Expansion: Assessing the Impact on Global IP Protection and Public Health (Ctr. for Intell. Prop. x Innov. Pol. Dec. 2022)
- Saurabh Vishnubhakat, The Commercial Value of Software Patents in the High-Tech Industry (Ctr. for the Prot. of Intell. Prop. May 2015)
- Saurabh Vishnubhakat, Toward the Substitutionary Promise of PTAB Review (Ctr. for Intell. Prop. x Innov. Pol. Apr. 2024)
- Bhamati Viswanathan & Adam Mossoff, Open-Access Mandates and the Seductively False Promise of “Free” (Ctr. for the Prot. of Intell. Prop. Apr. 2017)
- John F. Witherspoon, A Tribute to Judge Giles S. Rich (Ctr. for the Prot. of Intell. Prop. Apr. 2017)
Essays & Op-Eds
IPPI scholars play an active role in the intellectual property policy debate, writing numerous op-eds and essays about intellectual property rights and the technological, commercial, and creative innovation they facilitate. These essays and op-eds have been published in a wide variety of media sources.
Below are some selected highlights.
2025 Essays & Op-Eds
- Sandra Aistars, “Machines ‘Copy,’ Humans ‘Learn,’” The Well News (October 8, 2025)
- [Updates in progress]
2024 Essays & Op-Eds
- [Updates in progress]
2023 Essays & Op-Eds
- [Updates in progress]
2022 Essays & Op-Eds
- [Updates in progress]
2021 Essays & Op-Eds
- Jonathan M. Barnett, “Time to Punish Big Tech’s IP Theft,” AL DIA Opinion (November 16, 2021)
- Kristen Osenga, “FTC strays from fact-based enforcement and rule of law,” The Hill (November 16, 2021)
- Tabrez Y. Ebrahim, “Guest Post: Patents In Islamic Law,” Patently-O (November 3, 2021)
- Kristen Osenga, “COVID Vaccine IP Waiver: A Pathway to Fewer, Not More, Vaccines,” Released by the Regulatory Transparency Project of the Federalist Society (October 28, 2021)
- Kristen Osenga, “Changing the Story: Artificial Intelligence and Patent Eligibility,” Just Security (October 25, 2021)
- Kristen Osenga et al, “Putting Innovation First: The ‘New Madison Approach’ to Patent Licensing and Antitrust,” Released by the Regulatory Transparency Project of the Federalist Society (October 19, 2021)
- Camilla Hrdy, “Courtney Cox on Trade Secrets and Lying,” Written Description (October 10, 2021)
- Kristen Osenga, “Big Tech’s IP theft a common problem with a high cost,” Richmond Times Dispatch (September 26, 2021)
- Ted Sichelman, “Should Noncompete Clauses for Executives Be Legal?” The Wall Street Journal (September 22, 2021)
- Mark F. Schultz, “Trade Secrecy and Covid-19: How trade secrets and other IPRs underpin innovation and manufacturing of Covid-19 Vaccines,” Geneva Network (September 2021)
- Jonathan M. Barnett, “Startup Exit Strategies in the New Antitrust Era,” Bloomberg Law (August 11, 2021)
- Jonathan M. Barnett, “Old Ideas and the New New Deal,” Truth on the Market (August 2, 2021)
- Jonathan M. Barnett and Ted Sichelman, “The flawed case against noncompetes,” The Hill (July 29, 2021)
- Kristen Osenga, “Putting Together a Competitive Puzzle: How to Understand and Assemble the Pieces of the New Madison Approach,” CPI Antitrust Chronicle (July 27, 2021)
- Prashant Reddy T. and Yogesh Pai, “What’s the point of continuing a discussion on the unworkable TRIPs COVID-19 waiver proposal?” The IPKat Blog (July 13, 2021)
- Eric Claeys, “Covid-19 and Intellectual Property Rights,” Law & Liberty and VBLSA (July 6, 2021)
- Jonathan M. Barnett, “Going Back to Antitrust Basics,” Truth on the Market (July 1, 2021)
- Jonathan M. Barnett, “How IP Rights Keep Markets Free,” Hudson Institute (June 9, 2021)
- Kristen Osenga, “We Must Win the Race to 5G,” InsideSources (June 4, 2021)
- Jonathan M. Barnett, “Anti-innovation Policy,” Center for Strategic & International Studies (June 4, 2021)
- Jonathan M. Barnett, “Why Big Tech Likes Weak IP,” Cato Institute (Spring 2021)
- Jonathan M. Barnett, “Antitrust Lessons from AT&T’s M&A Fiasco,” Truth on the Market (May 24, 2021)
- Adam Mossoff and Devlin Hartline, “Google v. Oracle: A Copyrightability Decision Masquerading as Fair Use,” Washington Legal Foundation (May 7, 2021)
- Yogesh Pai, “WTO IP waiver too simplistic: Global vaccine tech-transfer needs other strategies,” CPIP Blog (April 29, 2021) (Originally posted in the Express Pharma edition of the Indian Express, Apr. 28, 2021)
- Kristen Osenga, “If You’re Sailing Into the Headwinds, You Might Be Going In the Wrong Direction,” RealClearMarkets (April 20, 2021)
- Jonathan M. Barnett, “Have tech platforms captured the Supreme Court?” The Hill (April 17, 2021)
- Kristen Osenga, “Online Symposium: Prof. Osenga’s Top 2020 Federal Circuit Patent Decisions,” FedCircuitBlog (March 30, 2021)
- Douglas C. Lippoldt and Mark F. Schultz, “An Opportunity for Leadership on Trade Secrets Protection in the Australia-UK Free Trade Agreement,” Institute for International Trade (March 25, 2021)
- David J. Kappos and Jonathan Barnett, “Covid-19 Vaccine Highlights the Need for Balanced Patent Policy,” Bloomberg Law (March 16, 2021)
- Mark Schultz, “The EU can put trust back into online commerce,” The Brussels Times (March 6, 2021)
- Jonathan Barnett, “Investors and Regulators Can Both Fall for Platform Bubbles,” Truth on the Market (March 2, 2021)
- Jonathan Barnett, “Antitrust by Fiat,” Truth on the Market (February 23, 2021)
- Jonathan Barnett, “How FTC v. Qualcomm Led to the Nvidia-Arm Acquisition,” Truth on the Market (February 17, 2021)
- Mark Schultz, “IP System Has Brought Light To The Tunnel — Mark Schultz,” CodeBlue (February 2, 2021)
- Jonathan Barnett, “How Patents Enable Mavericks and Challenge Incumbents,” IPWatchdog (January 24, 2021)
2020 Essays & Op-Eds
- Jonathan M. Barnett, “How and Why Almost Every Competition Regulator Was Wrong About Standard-Essential Patents,” CPI Antitrust Chronicle (December 21, 2020)
- Ted Sichelman, “The USPTO Patent Litigation Dataset: Open Source, Extensive Docket and Patent Number Data,” Patently-O (December 16, 2020)
- Mark Schultz, “How Can Asian Governments Foster Local Entertainment in the Streaming Era?” The Diplomat (December 11, 2020)
- Eric Priest et al., “Substantive Issues Plague China’s Patent Linkage Regime,” Law360 (November 10, 2020)
- Kristen Osenga, “Price Controls Are Intellectual Property Theft by a Different Name,” Townhall (October 27, 2020)
- Jonathan M. Barnett, “Antitrustifying Contract: Thoughts on Epic Games v. Apple and Apple v. Qualcomm,” Truth on the Market (October 26, 2020)
- Kristen Osenga, “Today’s Federal Trade Commission Is Taking One Giant Leap Backwards,” RealClearMarkets (October 21, 2020)
- Sandra Aistars, “High Court Oracle-Google Copyright War May Benefit Artists,” Law360 (October 8, 2020)
- Terrica Carrington, “Google v. Oracle: Supreme Court Hears Oral Arguments in ‘Copyright Case of the Decade,’” Copyright Alliance (October 8, 2020)
- Jonathan M. Barnett, “‘Unfair Use,’ Democracy and the Supreme Court,” The Hill (October 6, 2020)
- Jonathan Barnett, “Patent Tigers: Study Challenges ‘Patent Skeptics’ on the Benefits of Patents for Developing Economies,” IPWatchdog (June 21, 2020)
- Eric Priest & Sean Pager, “Senator Ron Wyden, Stop Harming Independent Creators,” IPWatchdog (June 11, 2020)
- Erika Lietzan, “The Tradeoffs Involved in New Drug Approval, Expanded Access, and Right to Try,” Objective Intent (March 21, 2020)
- Erika Lietzan, “Vaccine Approval 101,” Objective Intent (February 29, 2020)
- Erika Lietzan, “Emergency Use Authorizations,” Objective Intent (February 24, 2020)
- Kristen Osenga, “Anticompetitive or Hyper-Competitive? An Analysis of the FTC v. Qualcomm Oral Argument,” IPWatchdog (February 20, 2020)
- Mark Schultz, “Copyright Could Be the Next Way for Congress to Take on Big Tech,” The Verge (February 13, 2020)
- Kristen Osenga, “Saving Functional Claiming: The Mismatch of § 112 Reform in the § 101 Reform Debate,” Hudson Institute (January 10, 2020)
2019 Essays & Op-Eds
- Kevin Madigan & Adam Mossoff, “Five Years Later, the U.S. Patent System is Still Turning Gold to Lead,” IPWatchdog (December 15, 2019)
- Jonathan Barnett, “The Forgotten Virtues of Doing Nothing,” Truth on the Market (November 12, 2019)
- Erika Lietzan, “SSRN Reading List . . . or Device Regulation: What Role for Tort Law?” Objective Intent (September 30, 2019)
- Kristen Osenga, “Analyzing Judge Koh’s Errors in FTC v. Qualcomm: Highlights From Three Amicus Briefs,” IPWatchdog (September 16, 2019)
- Kristen Osenga, “The IEEE IPR Policy Amendments: Strategic Behavior and Feedback Loops,” IPWatchdog (September 11, 2019)
- Kevin Madigan, “Outdated Safe Harbor Laws Have No Place in Trade Agreements,” The Hill (August 23, 2019)
- Mark Schultz, “Is There Internet Life After 30?” The Hill (August 23, 2019)
- Erika Lietzan, “FDA’s Abandoned Proposal to Require Reporting of Data Falsification,” Objective Intent (August 21, 2019)
- Erika Lietzan, “The Big ‘Data Manipulation’ Story,” Objective Intent (August 12, 2019)
- Jonathan Barnett, “FTC v. Qualcomm: A Case of Regulatory Capture?” Truth on the Market (July 18, 2019)
- Jonathan Barnett, “Qualcomm Ruling a Case of Antitrust Gone Wrong,” The Hill (May 28, 2019)
- Erika Lietzan, “Case To Watch: Eagle v. Azar’s Hidden Chevron-Step-1 Issue,” Objective Intent (May 14, 2019)
- Sandra Aistars & Kevin Madigan, “CASE Act Promises Long-Overdue Access to Justice for Individuals and Small Businesses in the Arts,” IPWatchdog (May 9, 2019)
- Kristen Osenga, “Over-Regulation is Killing Medical Innovation – But It’s Not the Agency You Think,” Federalist Society (April 30, 2019)
- Kristen Osenga, “When the Patent System Works,” Washington Times (April 25, 2019)
- Kristen Osenga, “Moving the (Over-Regulated) Music Industry into Modern Times,” Federalist Society (April 24, 2019)
- Ted Sichelman, “Sichelman: A Defense And Explanation Of The U.S. News ‘Citation’ Ranking,” TaxProf Blog (March 20, 2019)
- Erika Lietzan, “Changes in the New Orange Book — Or, Too Much Time on My Hands,” Objective Intent (February 11, 2019)
- Kevin Madigan, “Netflix’s Alliance with the MPAA Signals a Shift,” Mister Copyright (January 25, 2019)
- Erika Lietzan, “Patent Term Restoration – Denied!” Objective Intent (January 7, 2019)
2018 Essays & Op-Eds
- Kristen Osenga, “What Happened to the Public’s Interest in Patent Law?” Federalist Society Review (December 26, 2018)
- Chris Katopis, “Recognizing the Limits of Government Procurement in the Pharmaceutical Industries,” CPIP Blog (December 20, 2018)
- Devlin Hartline, “CPIP Scholars Join Amicus Brief Arguing that the Government Cannot Petition for CBM Review,” CPIP Blog (December 19, 2018)
- Kathleen Wills, “Qualcomm Founder Dr. Irwin M. Jacobs Delights Attendees at CPIP’s Sixth Annual Fall Conference,” CPIP Blog (December 14, 2018)
- Kevin Madigan, “Flawed Marginal Cost Theory Should Not Be Applied to Intellectual Property,” CPIP Blog (November 29, 2018)
- Jonathan Barnett, “Antitrust Overreach: Undoing Cooperative Standardization in the Digital Economy,” CLS Blue Sky Blog (November 28, 2018)
- Rachelle Mortimer & Grant Ossler, “Arts & Entertainment Advocacy Clinic Students File Amicus Brief in Brammer v. Violent Hues” CPIP Blog (November 20, 2018)
- Chris Katopis, “A Cure Worse Than the Disease? Proposed Changes to European Patent Law are Threatening Pharmaceutical Innovation,” CPIP Blog (November 16)
- Kathleen Wills, “Proposed Misuse of Section 1498 Relies on the False Claim that Patents Are Not Property,” CPIP Blog (November 14, 2018)
- Devlin Hartline, “VIDEOS: Panel Presentations from the CPIP 2018 Fall Conference,” CPIP Blog (November 13, 2018)
- Evan Moore et al, “Proposal for Drug Price Controls is Legally Unprecedented and Threatens Medical Innovation,” CPIP Blog (November 5, 2018)
- Devlin Hartline, “VIDEO: Dr. Irwin M. Jacobs Delivers Keynote Address at CPIP 2018 Fall Conference,” CPIP Blog (October 30, 2018)
- Devlin Hartline & Aditi Kulkarni, “New ‘Invalidated’ Documentary Highlights the Problems With the PTAB: Free Screening on October 26,” CPIP Blog (October 25, 2018)
- Erika Lietzan, “SSRN Reading List; Genetically Modified Food and the Public’s Voice,” Objective Intent (October 23, 2018)
- Kristen Osenga, “Making Important Patents Worthless,” Washington Times (October 15, 2018)
- CPIP Staff, “IP for the Next Generation of Mobile Technology: How the Antitrust Division Devalued Standard-Essential Patents,” CPIP Blog (October 10, 2018)
- CPIP Staff, “IP for the Next Generation of Mobile Technology: How Ignorance of Standard Setting Operations Hinders Innovation,” CPIP Blog (October 9, 2018)
- CPIP Staff, “IP for the Next Generation of Mobile Technology: How IEEE’s Policy Changes Have Created Uncertainty for Innovators,” CPIP Blog (October 8, 2018)
- Erika Lietzan, “SSRN Reading List — Is ‘Milk’ Worth Fighting For?” Objective Intent (October 8, 2018)
- CPIP Staff, “Focusing on IP for the Next Generation of Mobile Technology,” CPIP Blog (October 5, 2018)
- Erika Lietzan, “SSRN Reading List — Food Law and Policy Articles,” Objective Intent (October 5, 2018)
- Erika Lietzan, “The Puzzling Uncertainty About Umbrella Exclusivity,” Objective Intent (September 26, 2018)
- Chris Holman, “Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection,” Intellectual Property Watch (September 21, 2018)
- Erika Lietzan, “Cannabis and the Often Overlooked Drug Exclusion Rule,” Objective Intent (September 19, 2018)
- Erika Lietzan, “The Patent Dance: A Reasonable Response to the Specter of Reasonable Royalties,” Objective Intent (September 12, 2018)
- Erika Lietzan, “Biosimilar Patent Litigation: the ‘Finish What You Started’ Rule,” Objective Intent (September 10, 2018)
- CPIP Staff, “CPIP Announces Leadership Transitions,” CPIP Blog (August 21, 2018)
- Erika Lietzan, “Whither FDA’s Drug Approval Paradigm? — A Debate from Recent FDA Law SSRN Postings,” Objective Intent (August 17, 2018)
- Kevin Madigan & Adam Mossoff, “Study Finds IEEE’s 2015 Patent Policy Sowing Uncertainty and Slowing Innovation,” CPIP Blog (July 17, 2018)
- Kevin Madigan, “Will the EU Finally Hold Internet Giants Accountable?” CPIP Blog (July 3, 2018)
- Kristen Osenga, “Qualcomm vs. Apple: Who’s the Real Bully?” The Daily Caller (July 1, 2018)
- David Lund, “Rep. Massie Introduces New Legislation to Restore America’s Patent System,” CPIP Blog (June 29, 2018)
- Kevin Madigan & Adam Mossoff, “The Value of Public Data: Update to ‘Turning Gold to Lead,’” CPIP Blog (June 28, 2018)
- Devlin Hartline, “New CPIP Policy Brief: An Unwise Move to Discriminate Against Pharmaceutical Patents,” CPIP Blog (June 7, 2018)
- Kevin Madigan, “Sometimes Fair Use Takes a Little Effort (and That’s a Good Thing),” Mister Copyright (May 31, 2018)
- Matthew Barblan, “Despite Professors’ Misleading Rhetoric, CLASSICS is a Big Win for Everyone,” CPIP Blog (May 29, 2018)
- Kevin Madigan, “USTR Report Highlights Concerns over Canada’s Treatment of IP,” Mister Copyright (May 21, 2018)
- CPIP Staff, “CPIP Scholars Examine the Flaws in the Term ‘Evergreening,’” CPIP Blog (May 1, 2018)
- Eric Priest et al., “Tariffs Are the Wrong Weapon in Fight Against China’s Pirates – Here’s the Right One,” The Conversation (April 30, 2018)
- Devlin Hartline, “CPIP Scholars To Federal Circuit: Protect Innovation in the Life Sciences,” CPIP Blog (April 30, 2018)
- Kevin Madigan, “Usual Suspects Fight Effort to Impose Online Accountability in Europe,” Mister Copyright (April 30, 2018)
- David Lund, “CPIP and ITIF Release Innovate4Health Report on Role of IP in Solving Global Health Challenges,” CPIP Blog (April 26, 2018)
- David Lund, “Department of Justice Recognizes Importance of Reliable Patent Rights in Innovation Economy,” CPIP Blog (April 23, 2018)
- Erika Lietzan, “FDA Law SSRN Reading List – February and March 2018, 2/3,” Objective Intent (April 18, 2018)
- Matthew Barblan & Kevin Madigan, “CLASSICS Act Provides Long Overdue Recognition for Legacy Recording Artists,” CPIP Blog (April 16, 2018)
- Erika Lietzan, “SSRN Reading List February and March, 1 of 3,” Objective Intent (April 13, 2018)
- Kevin Madigan, “CASE Act Set to Empower Creators and Impose Accountability,” Mister Copyright (March 31, 2018)
- Erika Lietzan, “Pediatric Exclusivity (3 of 3): Amgen v. Hargan,” Objective Intent (March 24, 2018)
- David Lund, “The STRONGER Patents Act: The House Receives Its Own Legislation to Protect Our Innovation Economy,” CPIP Blog (March 20, 2018)
- Erika Lietzan, “Pediatric Exclusivity (2 of 3): Amgen v. Hargan,” Objective Intent (March 14, 2018)
- Michael O’Keefe, “SaTo Pan Delivers a Sustainable Solution to the Sanitation Crisis in Developing Nations,” CPIP Blog (March 13, 2018)
- Kevin Madigan, “Panel on Streaming Media Boxes Explores the New Face of Piracy,” Mister Copyright (March 12, 2018)
- Erika Lietzan, “FDA Law SSRN Reading List – December ’17 & January ’18,” Objective Intent (March 6, 2018)
- Alex Summerton & Nick Churchill, “Daktari Diagnostics Takes on Africa’s Healthcare Challenges One Diagnostic Device at a Time,” CPIP Blog (March 6, 2018)
- Devlin Hartline, “CPIP Scholars Ask Federal Circuit to Fix Patent Eligibility Doctrine in Cleveland Clinic Appeal,” CPIP Blog (March 5, 2018)
- Erika Lietzan, “Pediatric Exclusivity 101,” Objective Intent (March 3, 2018)
- Devlin Hartline, “New White Paper Explores the Importance of Property Rights to National Wealth and Security,” CPIP Blog (February 28, 2018)
- Kevin Madigan, “Updated TickBox Injunction and the Fight Against Add-Ons,” Mister Copyright (February 27, 2018)
- Gleb Savich, “Augmented Reality Technology Helps Bring Surgical Expertise to Conflict Zones and the Developing World,” CPIP Blog (February 27, 2018)
- Gleb Savich, “Indian Startup Develops Nanomaterial Filter to Help Solve Global Drinking Water Crisis,” CPIP Blog (February 21, 2018)
- Alex Summerton, “DNAe Enhances HIV Treatment By Monitoring the Effectiveness of Antiretroviral Therapy,” CPIP Blog (February 15, 2018)
- Devlin Hartline, “Letter to Antitrust Chief Applauds DOJ’s New Evidence-Based Approach to IP Enforcement,” CPIP Blog (February 13, 2018)
- Kevin Madigan, “TickBox Injunction Targets Blatant Inducement of Infringement,” Mister Copyright (February 11, 2018)
- Devlin Hartline, “U.S. Innovation Economy Falls Even Further in Latest GIPC Patent Rankings,” CPIP Blog (February 8, 2018)
- Kristen Osenga, “US Takes One Step Forward, Two Steps Back on Innovation,” The Hill (February 7, 2018)
- Nick Churchill, “Nike’s Innovations Provide Comfort and Independence to People with Disabilities,” CPIP Blog (February 6, 2018)
- Kevin Madigan, “Concerns over ALI Copyright Restatement Leave Project in Limbo,” Mister Copyright (January 31, 2018)
- Kevin Madigan, “NAFTA Shouldn’t Include Outdated Internet Safe Harbors,” The Hill (January 27, 2018)
- Erika Lietzan, “Food Additive Approvals — and Patents,” Objective Intent (January 7, 2018)
2017 Essays & Op-Eds
- Kevin Madigan, “Study on Expanded ‘User Rights’ Fails Econometric Scrutiny,” Mister Copyright (December 23, 2017)
- Erika Lietzan, “You Can Dance If You Want To,” Objective Intent (December 22, 2017)
- Kevin Madigan, “Monkeys, Turtles, and Cheerleaders: Copyright in 2017 and Beyond,” Mister Copyright (December 18, 2017)
- Gleb Savich, “Embrace Infant Warmers Help Save Lives of Preterm Babies in Developing Countries,” CPIP Blog (December 7, 2017)
- Devlin Hartline, “CPIP Scholars File Amicus Brief Urging Supreme Court to Fix Section 101,” CPIP Blog (December 6, 2017)
- Erika Lietzan, “FDA Law SSRN Reading List – October and November (Part 2 of 2),” Objective Intent (December 5, 2017)
- Erika Lietzan, “FDA Law SSRN Reading List – October and November (Part 1 of 2),” Objective Intent (December 3, 2017)
- Kevin Madigan, “A New NAFTA Must Protect the Rights of Copyright Owners and Creators,” Mister Copyright (November 30, 2017)
- Kristen Osenga, “Supreme Court Must Reinforce US as Preeminent Innovation Superpower,” The Hill (November 27, 2017)
- Kevin Madigan, “Debunking Criticism of the Copyright Small Claims Act,” Mister Copyright (November 20, 2017)
- Alex Summerton, “CPIP Fall Conference Papers Highlight How Intellectual Property Rights Promote Global Prosperity,” CPIP Blog (November 17, 2017)
- Alex Summerton, “Miriam Bridges the Gap Between Developing-World Infrastructure and Cancer Detection,” CPIP Blog (November 7, 2017)
- Mark Schultz, “Digital Age Changes All the Rules on Intellectual Property,” The Hill (November 6, 2017)
- Erika Lietzan, “Thoughts on ‘Reciprocal Marketing Approval,’” Objective Intent (November 3, 2017)
- Nick Churchill, “Nutriset Uses Patents and Trademarks to Fight Severe Malnutrition Across the Globe,” CPIP Blog (October 31, 2017)
- Kevin Madigan, “Pulitzer Prize-Winning Author T.J. Stiles Makes the Case for Copyright,” CPIP Blog (October 30, 2017)
- Erika Lietzan, “FDA Law SSRN Reading List (September 2017),” Objective Intent (October 28, 2017)
- Erika Lietzan, “Hatch-Waxman Comments – Status Report (Part II),” Objective Intent (October 23, 2017)
- Erika Lietzan, “Hatch-Waxman Comments – Status Report (Part I),” Objective Intent (October 17, 2017)
- Kevin Madigan, “Small Claims Bill Aims to Empower Copyright Owners and Creators,” Mister Copyright (October 16, 2017)
- Erika Lietzan, “Data Exclusivity for Medical Devices,” Objective Intent (October 10, 2017)
- Adam Mossoff & David Lund, “The Problems With the PTAB,” IAM Magazine (October 1, 2017)
- Kristen Osenga, “The Patent Conundrum,” Washington Times (October 1, 2017)
- Kevin Madigan, “New Report Highlights Danger of Stream-Based Infringement,” Mister Copyright (September 23, 2017)
- Kevin Madigan, “Register of Copyrights Selection and Accountability Act: A Step Towards a Modern Copyright Office,” Copyright & New Media Law (Fall 2017)
- Erika Lietzan, “FDA Law SSRN Reading List (August 2017),” Objective Intent (September 14, 2017)
- Erika Lietzan, “FDA’s Reliance on User Fees,” Objective Intent (September 4, 2017)
- Kevin Madigan, “Stream Ripping Emerges as the New Face of Music Piracy,” Mister Copyright (August 31, 2017)
- Andrew Levey, “New Oxygen Machine Technology Confronts Blackouts in Emerging Nations,” CPIP Blog (August 30, 2017)
- Kevin Madigan, “Mayweather v. McGregor Warrants Preemptive Anti-Piracy Efforts,” CPIP Blog (August 23, 2017)
- Erika Lietzan, “ANDAs Before Hatch-Waxman,” Objective Intent (August 19, 2017)
- Devlin Hartline, “Court Confirms the Obvious: Aiding and Abetting Criminal Copyright Infringement Is a Crime,” Law Theories (August 16, 2017)
- Devlin Hartline, “The PTAB’s Regulatory Overreach and How it Cripples the Innovation Economy,” CPIP Blog (August 16, 2017)
- Kevin Madigan, “CPIP Affiliate Scholar Erika Lietzan Testifies at HJC Hearing on FDA Approval Process,” CPIP Blog (August 15, 2017)
- Gabrielle Eriquez, “Nanobiosym’s Gene-RADAR Brings Real-Time Results for Zika Testing,” CPIP Blog (August 7, 2017)
- Erika Lietzan, “FDA Law SSRN Reading List (July 2017),” Objective Intent (August 1, 2017)
- Kevin Madigan, “Richard Prince and the Increasingly Permissive Treatment of Infringement,” Mister Copyright (July 31, 2017)
- Erika Lietzan, “The Unapproved Drugs Conundrum,” Objective Intent (July 24, 2017)
- Kevin Madigan, “International Trade Administration Report Highlights Strong Markets, Persistent Piracy,” CPIP Blog (July 18, 2017)
- Ted Sichelman, “Does The Supreme Court Understand The Innovation Economy?” Forbes (July 12, 2017)
- Erika Lietzan, “Could FDA Enforce the ‘Requirement’ to Provide the Biosimilar Marketing Application?” Objective Intent (July 5, 2017)
- Bhamati Viswanathan, “GRIT Leveraged Freedom Chair Brings Mobility to Developing World,” CPIP Blog (July 5, 2017)
- Nick Churchill, “Treating Neonatal Jaundice in the Developing World with D-Rev’s Brilliance,” CPIP Blog (June 27, 2017)
- Kevin Madigan, “Judgment Against Sci-Hub is a Win for Authors and Publishers,” CPIP Blog (June 27, 2017)
- Erika Lietzan, “Origins of the Theory that the ‘Patent Dance’ Might Not Be Required: Omission of Process Patents,” Objective Intent (June 27, 2017)
- Ted Sichelman, “Sometimes, Information Wants To Be Expensive,” Jotwell (June 26, 2017)
- Kevin Madigan, “As Investment Moves Overseas, the US Must Restore its Gold-Standard Patent System,” CPIP Blog (June 22, 2017)
- David Lund, “The STRONGER Patents Act: Important Legislation to Protect Our Innovation Economy,” CPIP Blog (June 21, 2017)
- Erika Lietzan, “Sandoz v. Amgen: What The Court Settled, What It Didn’t, And What Might Come Next,” Health Affairs Blog (June 19, 2017)
- Erika Lietzan, “Supporting FDA Product Reviews with User Fees Alone,” Objective Intent (June 17, 2017)
- Kevin Madigan, “Alliance for Creativity and Entertainment (ACE) Unites to Fight Online Piracy,” CPIP Blog (June 14, 2017)
- David Lund, “CPIP Co-Founder Testifies at House Judiciary Committee Hearing on IP,” CPIP Blog (June 13, 2017)
- David Lund & Matthew Barblan, “Leveling the Antitrust Playing Field,” Washington Times (June 11, 2017)
- Erika Lietzan, “(FDA) User Fee Churn,” Notice & Comment (June 11, 2017)
- Erika Lietzan, “Demystifying Drug Importation after Impression v. Lexmark,” Patently-O (June 6, 2017)
- Mark Schultz, “Innovation: History’s Great Free Lunch,” WIPO Magazine (June 2017)
- Kevin Madigan, “Increase in IP-based Extortion Reveals True Nature of Piracy,” Mister Copyright (May 31, 2017)
- David Lund & Matthew Barblan, “Foreign Antitrust Regulators Are Threatening American Innovation,” CPIP Blog (May 17, 2017)
- Mandi Hart, “From Star Wars to La La Land: How Intellectual Property Fuels Films,” CPIP Blog (May 11, 2017)
- Adam Mossoff & Bhamati Viswanathan, “Explaining Efficient Infringement,” CPIP Blog (May 11, 2017)
- Kevin Madigan, “In Defense of an Inclusive IP Conversation,” CPIP Blog (May 9, 2017)
- CPIP Staff, “New CPIP Policy Brief: Open-Access Mandates and the Seductively False Promise of ‘Free,’” CPIP Blog (May 4, 2017)
- Kevin Madigan, “An Ever-Weakening Patent System is Threatening the Future of American Innovation,” CPIP Blog (April 28, 2017)
- CPIP Staff, “CPIP Publishes Prof. John F. Witherspoon’s Tribute to the Late Judge Giles S. Rich,” CPIP Blog (April 27, 2017)
- CPIP Staff, “CPIP & ITIF Launch ‘Innovate4Health’ Policy Research Initiative,” CPIP Staff (April 26, 2017)
- Devlin Hartline, “The Drug Innovation Paradox: Matching Incentives to Market Realities,” CPIP Blog (April 19, 2017)
- Jaci Arthur, “Meeting the Needs of Rural Africa with Fyodor’s Point-of-Care Testing for Malaria,” CPIP Blog (April 17, 2017)
- David Lund, “Junk Science Used to Erode Innovation-Fueling Patent Laws,” The Hill (April 9, 2017)
- David Lund, “The Lawless Body – ‘Prior Judicial Opinions Did Not Bind the PTAB,’” CPIP Blog (April 6, 2017)
- David Lund, “Protecting Patients with VanishPoint Retractable Syringes,” CPIP Blog (March 30, 2017)
- Kevin Madigan, “Register of Copyrights Selection and Accountability Act is First Step Towards a Modern Copyright Office,” CPIP Blog (March 29, 2017)
- Devlin Hartline, “Another Huge Setback in CloudFlare’s Quixotic Campaign to Protect Pirate Sites,” CPIP Blog (March 28, 2017)
- David Lund, “Lobbyists Continue to Invoke Discredited Junk Science to Push Patent Legislation,” CPIP Blog (March 28, 2017)
- Bhamati Viswanathan, “Event Recap: Great Inventors and the Patent System,” CPIP Blog (March 20, 2017)
- Kevin Madigan, “mPedigree Battles Counterfeit Drugs Through Innovative Verification System,” CPIP Blog (March 17, 2017)
- Kevin Madigan, “Kodi Software Enabling Widespread Copyright Infringement,” CPIP Blog (March 15, 2017)
- Maryna Koberidze, “Eye Exams On-the-Go with PEEK,” CPIP Blog (March 10, 2017)
- Bhamati Viswanathan, “Global Good’s ‘Arktek’: A Life-Saving Super-Thermos Vaccine Cooler,” CPIP Blog (March 9, 2017)
- Devlin Hartline, “CPIP Scholars Ask Supreme Court to Resist Call to Restrict Venue Choices for Patent Owners,” CPIP Blog (March 9, 2017)
- Kevin Madigan, “Trusted Notifier Program Defended Against Misleading Rhetoric,” CPIP Blog (March 2, 2017)
- Devlin Hartline, “CPIP’s Sandra Aistars & Scalia Law Alumnae Urge Federal Circuit to Protect Creators and Rein In Fair Use in Oracle v. Google,” CPIP Blog (February 28, 2017)
- David Lund, “44 Law, Economics, and Business Professors Urge Supreme Court to take Presumptive Approach to Patent Exhaustion,” CPIP Blog (February 24, 2017)
- Bhamati Viswanathan, “Shaping Fair Use to Promote Fair Markets,” CPIP Blog (February 24, 2017)
- Rebecca Cusey, “Oracle v. Google: Expansive Fair Use Harms Creators,” CPIP Blog (February 23, 2017)
- Kevin Madigan, “What Would Judge Gorsuch Mean for Fair Use?” CPIP Blog (February 23, 2017)
- Kevin Madigan, “CPIP Scholars Join Open Letter Providing IP Guidance for New Administration and Congress,” CPIP Blog (February 22, 2017)
- Erika Lietzan, “How Colombia’s Biosimilar Regulation Departs From International Norms,” PAHO Pan American Journal of Public Health (February 22, 2017)
- David Lund, “CPIP Scholars File Amicus Brief Urging Consideration of Claimed Inventions as a Whole,” CPIP Blog (February 21, 2017)
- Bhamati Viswanathan, “Can Copyright Help Fight Censorship in China?” CPIP Blog (February 17, 2017)
- David Lund, “IPO Publishes Analysis of Recently Released Legislative Proposal,” CPIP Blog (February 16, 2017)
- Devlin Hartline, “SONA and Songwriters Fight DOJ’s Misguided 100% Licensing Rule,” CPIP Blog (February 9, 2017)
- Devlin Hartline, “CPIP Founders File Amicus Brief on Behalf of 11 Law Professors in Converse v. ITC,” CPIP Blog (February 3, 2017)
- David Lund, “IPO Proposes Legislative Solution to the Morass of Patent Eligibility,” CPIP Blog (February 1, 2017)
- Kevin Madigan, “IP Scholars Explain Why We Shouldn’t Use SurveyMonkey to Select Our Next Register of Copyrights,” CPIP Blog (January 31, 2017)
- Maryna Koberidze, “How IP Helps Individuals,” CPIP Blog (January 25, 2017)
- Andrew Baluch & Devlin Hartline, “Intellectual Property Backgrounds of President Trump’s Potential Supreme Court Nominees,” CPIP Blog (January 23, 2017)
- David Lund, “Trading Technologies v. CQG: Federal Circuit Gets One Right On Software Patents,” CPIP Blog (January 19, 2017)
- Maryna Koberidze, “Creative Upstarts and Startups: How IP Creates Opportunities and Opens Doors,” CPIP Blog (January 11, 2017)
- CPIP Staff, “CPIP, USPTO, & Lemelson Center Host ‘Great Inventors’ Panel Discussion at American History Museum,” CPIP Blog (January 10, 2017)
2016 Essays & Op-Eds
- Kevin Madigan, “Librarians’ Contradictory Letter Reveals an Alarming Ignorance of the Copyright System,” CPIP Blog (December 19, 2016)
- David Lund, “Congress Can Save Software Patents by Repeating One of Its Successes,” IPWatchdog (December 11, 2016)
- Adam Mossoff & Charles Sauer, “Congress Saved Software in 1980, and It Should Do It Again Today,” The Weekly Standard (December 10, 2016)
- David Lund, “Members of Congress Express Concerns About Abuses of PTO’s Inter Partes Review System,” CPIP Blog (December 9, 2016)
- David Lund, “New Paper Exposes Flaws in Smallest Salable Patent-Practicing Unit Rule,” CPIP Blog (December 8, 2016)
- Ryan Holte, “Patent Submission Policies: Is it Time to Reconsider Commercialization Communications?” IPWatchdog (November 14, 2016)
- David Lund, “New Paper Addresses Flaws in Patent Holdup Theory,” CPIP Blog (November 9, 2016)
- Kevin Madigan, “Digital Single Market Must Protect the Rights of All Authors and Publishers,” Mister Copyright (October 31, 2016)
- David Lund, “Federal Circuit Improperly Extends Abstract Idea Exception to Industrial Machines,” CPIP Blog (October 27, 2016)
- Mark Schultz & Kevin Madigan, “It’s Time to Fix the Global Patent System Before It Breaks Under the Weight of New Applications,” IPWatchdog (October 24, 2016)
- CPIP Staff, “New CPIP Report: The Global Patent Pendency Problem,” CPIP Blog (October 24, 2016)
- Kristen Osenga, “The FTC’s PAE Study: Doing More Harm Than Good,” IPWatchdog (October 20, 2016)
- Kevin Madigan, “Content Thief Turned Content Creator Rails Against Piracy.” Mister Copyright (October 15, 2016)
- Devlin Hartline, “Second Circuit Brings Some Sanity Back to Transformative Fair Use,” CPIP Blog (October 13, 2016)
- Devlin Hartline, “FTC’s PAE Study Makes Unsupported Recommendations,” CPIP Blog (October 6, 2016)
- Kevin Madigan, “Rejection of DOJ Consent Decree Interpretation is a Win for Songwriters,” Mister Copyright (September 28, 2016)
- Devlin Hartline, “Professors Mislead FCC on Basic Copyright Law,” CPIP Blog (September 28, 2016)
- Kevin Madigan, “UNITAID’s Request for Suggestions on Breaking Down IP Barriers Ignores Harmful Patent Delay,” CPIP Blog (September 26, 2016)
- Devlin Hartline, “Criminal Copyright Infringement is Crime of ‘Moral Turpitude,’” Law Theories (September 26, 2016)
- Devlin Hartline, “Federal Circuit Again Finds Computer-Implemented Invention Patent Eligible,” CPIP Blog (September 16, 2016)
- Kevin Madigan, “European Union Draws a Line on Infringing Hyperlinks,” Mister Copyright (September 12, 2016)
- CPIP Staff, “Scalia Law Alums Help Arts & Entertainment Advocacy Clinic Draft Influential Amicus Brief,” CPIP Blog (September 13, 2016)
- Kevin Madigan, “Despite What You Hear, Notice and Takedown is Failing Creators and Copyright Owners,” CPIP Blog (August 24, 2016)
- Devlin Hartline, “CloudFlare’s Desperate New Strategy to Protect Pirate Sites,” CPIP Blog (August 17, 2016)
- Bhamati Viswanathan, “The European Union Extends Copyright in Design—and Critics Balk (Yet Again),” CPIP Blog (August 15, 2016)
- CPIP Staff, “Law Professors & Economists Urge Caution on VENUE Act in Letter to Congress,” CPIP Blog (August 1, 2016)
- Bhamati Viswanathan, “CPIP Scholars File Amicus Brief in Trading Technologies v. CQG,” CPIP Blog (July 29, 2016)
- Kevin Madigan, “Letter on FCC Set-Top Box Regulation Once Again Confuses the Issue,” CPIP Blog (July 27, 2016)
- Kevin Madigan, “The Dangerous Combination of Content Theft and Malware,” Mister Copyright (July 24, 2016)
- Adam Mossoff & Kevin Madigan, “Federal Circuit Brings Some Clarity and Sanity Back to Patent Eligibility Doctrine,” CPIP Blog (July 14, 2016)
- Erika Lietzan, Kevin Madigan, & Mark Schultz, “Proposed CREATES Act Threatens Patent Owners’ Rights,” CPIP Blog (July 5, 2016)
- Devlin Hartline, “Do As I Say, Not As I Do: Google’s Patent Transparency Hypocrisy,” CPIP Blog (June 30, 2016)
- Matthew Barblan & Kevin Madigan, “Three Years Later, DMCA Still Just as Broken,” CPIP Blog (June 30, 2016)
- Devlin Hartline, “Second Circuit Deepens Red Flag Knowledge Circuit Split in Vimeo,” CPIP Blog (June 28, 2016)
- Devlin Hartline & Kevin Madigan, “How Strong Patents Make Wealthy Nations,” CPIP Blog (June 24, 2016)
- Kevin Madigan, “Advertiser Pledge Sets Example of Accountability in the Fight Against Piracy,” Mister Copyright (June 23, 2016)
- Devlin Hartline, “Capitol Records v. Vimeo: Courts Should Stop Coddling Bad Actors in Copyright Cases,” IPWatchdog (June 22, 2016)
- CPIP Staff, “IP Scholars to FCC: It’s Not About ‘The Box,’” CPIP Blog (June 15, 2016)
- Kevin Madigan, “Radiohead Video Makes Unauthorized Use of Fictional Characters,” Mister Copyright (June 9, 2016)
- Matthew Barblan & Kevin Madigan, “FCC’s Extreme Proposal Threatens the Livelihood of Creators,” CPIP Blog (May 25, 2016)
- Kevin Madigan, “Google Image Search and the Misappropriation of Copyrighted Images,” Mister Copyright (May 2, 2016)
- Kevin Madigan & Devlin Hartline, “Copyright Policy Should Be Based On Facts, Not Rhetoric,” IPWatchdog (April 29, 2016)
- Mark Schultz & Philip Stevens, “How Canada’s Catch-22 Drug-Patent Laws are Stifling Innovation,” Financial Post (April 28, 2016)
- Kevin Madigan & Devlin Hartline, “Separating Fact from Fiction in the Notice and Takedown Debate,” CPIP Blog (April 25, 2016)
- Devlin Hartline, “Acknowledging the Limitations of the FTC’s PAE Study,” CPIP Blog (April 25, 2016)
- Sandra Aistars, “A New Librarian of Congress and a New Copyright Office,” CPIP Blog (April 20, 2016)
- Kristen Osenga, “Why the FTC Study on PAEs is Destined to Produce Incomplete and Inaccurate Results,” IPWatchdog (April 20, 2016)
- Sandra Aistars, “Intellectual Property Professors Call on Congress to Modernize the Copyright Office,” IPWatchdog (April 15, 2016)
- Rebecca Cusey, “Middle Class Artists Want a DMCA System That Works,” CPIP Blog (April 1, 2016)
- Devlin Hartline, “Copyright Scholars: Courts Have Disrupted the DMCA’s Careful Balance of Interests,” CPIP Blog (April 1, 2016)
- Devlin Hartline, “Changes to Patent Venue Rules Risk Collateral Damage to Innovators,” CPIP Blog (March 22, 2016)
- Adam Mossoff & Devlin Hartline, “No Consensus That Broad Patent ‘Reform’ is Necessary or Helpful,” The Hill (March 9, 2016)
- Chris Holman, “Copyright for Engineered DNA (Part 1, Part 2, Part 3),” GQ Life Sciences (February 23-March 8, 2016)
- Kevin Madigan, “Artur Fischer’s Life Illustrates the Power of Invention,” CPIP Blog (February 9, 2016)
- Devlin Hartline, “Attacking the Notice-and-Staydown Straw Man,” CPIP Blog (February 3, 2016)
- Kristen Osenga, “Patent ‘Reform’: What We Need First Is A Role Reversal,” ACSblog (January 26, 2016)
- Devlin Hartline, “Notice-and-Staydown and Google Search: The Whack-A-Mole Problem Continues Unabated,” CPIP Blog (January 17, 2016)
- Devlin Hartline, “Endless Whack-A-Mole: Why Notice-and-Staydown Just Makes Sense,” CPIP Blog (January 14, 2016)
- Rebecca Cusey, “Jennifer Lawrence Movie ‘Joy’ Highlights the Need for Patent Protection,” CPIP Blog (January 7, 2016)
- Devlin Hartline, “How Patents Help Startups Grow, Innovate, and Succeed,” CPIP Blog (January 6, 2016)
2015 Essays & Op-Eds
- Devlin Hartline, “One Step Closer to Mega Justice: Kim Dotcom Loses Extradition Hearing,” Law Theories (December 23, 2015)
- Devlin Hartline, “BMG v. Cox: ISP Liability and the Power of Inference,” Law Theories (December 20, 2015)
- Devlin Hartline & Matthew Barblan, “Protecting Artists from Streaming Piracy Benefits Creativity and Technology,” The Hill (December 10, 2015)
- Devlin Hartline, “Principles and Priorities to Guide Congress’s Ongoing Copyright Review,” CPIP Blog (December 8, 2015)
- Mark Schultz, “Debunking Myths About the Proposed Federal Trade Secrets Act,” CPIP Blog (November 17, 2015)
- Adam Mossoff & Devlin Hartline, “State Laws on Patent Demand Letters are Unnecessary Threats to the Innovation Economy,” Morning Consult (October 16, 2015)
- Terrica Carrington, “Strong IP Protection Provides Inventors and Creators the Economic Freedom to Create,” IPWatchdog (October 15, 2015)
- Devlin Hartline & Terrica Carrington, “Let’s Get Real About Kim Dotcom: The Indictment Clearly Alleges Felony Copyright Infringement,” CPIP Blog (September 22, 2015)
- Devlin Hartline, “Ninth Circuit Gets Fair Use Wrong to the Detriment of Creators,” CPIP Blog (September 16, 2015)
- Brad Sheafe, “Google’s Patent Starter Program: What it Really Means for Startups,” CPIP Blog (September 8, 2015)
- Devlin Hartline, “The MovieTube Litigation: Who Needs SOPA?” Law Theories (August 31, 2015)
- Devlin Hartline, “Federal Circuit Should Reconsider Ariosa v. Sequenom: The Panel Decision Threatens Modern Innovation,” IPWatchdog (August 30, 2015)
- Terrica Carrington & Devlin Hartline, “Patent Licensing and Secondary Markets in the Nineteenth Century,” CPIP Blog (August 14, 2015)
- Devlin Hartline, “Creators, Innovators, and Appropriation Mechanisms,” CPIP Blog (August 11, 2015)
- Matt McIntee, “Making Copyright Work for Creative Upstarts,” CPIP Blog (August 4, 2015)
- Devlin Hartline & Matthew Barblan, “Digital Goods and the ITC: The Most Important Case That Nobody is Talking About,” CPIP Blog (July 29, 2015)
- Devlin Hartline, “How Rhetorical Epithets Have Led the FTC Astray in its Study of Patent Licensing Firms,” CPIP Blog (July 6, 2015)
- Patent Publius, “Federal Circuit Threatens Innovation: Dissecting the Ariosa v. Sequenom Opinion,” CPIP Blog (June 23, 2015)
- Devlin Hartline, “Unintended Consequences of ‘Patent Reform’: The Customer Suit Exception,” CPIP Blog (June 16, 2015)
- Chris Holman, “Federal Circuit Decides Ariosa, and It’s Not Good News for Innovation in the Life Sciences,” Holman’s Biotech IP Blog (June 12, 2015)
- Devlin Hartline, “CloudFlare Enjoined From Aiding Infringers: Internet Unbroken,” CPIP Blog (June 11, 2015)
- Adam Mossoff & Mark Schultz, “Don’t Pull Up the Ladder: Congressional Inventors Should Oppose Weakening Patents,” IPWatchdog (June 10, 2015)
- Mark Schultz & Devlin Hartline, “Copyright’s Republic: Promoting an Independent and Professional Class of Creators and Creative Businesses,” CPIP Blog (June 5, 2015)
- Mark Schultz & Devlin Hartline, “Copyright’s Republic: Copyright for the Last and the Next 225 Years,” CPIP Blog (June 5, 2015)
- Kristen Osenga, “Goodlatte and Google or the Good of the Economy?” Richmond Times-Dispatch (April 10, 2015)
- CPIP Staff, “CPIP Supports Guidelines for the Protection of Fundamental IP Rights,” CPIP Blog (February 2, 2015)
- Kristen Osenga, “Congress Should Regulate Behavior, Not Business Models, When Crafting Patent Legislation,” The Hill (January 27, 2015)
- Richard Epstein, “Controlling Chinese Antitrust Abuses Against Foreign Patent Owners Requires Us to Make Sound Decisions At Home,” Forbes (January 8, 2015)
2014 Essays & Op-Eds
- Chris Holman, “The Courts and Patent Office are Killing Medical Innovation,” The Hill (November 14, 2014)
- CPIP Staff, “Cohen et al. ‘Patent Trolls’ Study Uses Incomplete Data, Performs Flawed Empirical Tests, and Makes Unsupportable Findings,” CPIP Blog (November 12, 2014)
- Mark Schultz, “Bridging the Innovation Gap,” The Hindu (November 4, 2014)
- CPIP Staff, “IP Promotes Progress by Securing the Individual Liberty of Inventors and Creators,” CPIP Blog (October 20, 2014)
- CPIP Staff, “The Common Economic Case for Patents and Copyrights,” CPIP Blog (October 19, 2014)
- Adam Mossoff & Mark Schultz, “Intellectual Property Unites Creators and Innovators,” CPIP Blog (October 17, 2014)
- Kristen Osenga, “Policy Makers Must Realize Not All Licensing-Based Businesses Are the Same,” IAM Magazine (October 1, 2014)
- Adam Mossoff & Mark Schultz, “Intellectual Property, Innovation and Economic Growth: Mercatus Gets it Wrong,” CPIP Blog (August 28, 2014)
- Adam Mossoff & Mark Schultz, “Intellectual Property and Economic Prosperity: Friends or Foes?” TechPolicyDaily (August 27, 2014)
- Mark Schultz, “Aereo Decision a Boon, Not a Bane for Innovation,” American Enterprise Institute (June 26, 2014)
- Mark Schultz, “Supreme Court Says Aereo Has to Play by the Rules,” CPIP Blog (June 25, 2014)
- Matthew Barblan, “Alice Gets the Most Important Question Right,” CPIP Blog (June 19, 2014)
- Adam Mossoff & Brian O’Shaughnessy, “Supreme Court Revises Fee-Shifting Rules in Patent Cases: Weeding out Bad Actors in a Level Playing Field,” CPIP Blog (May 6, 2014)
- Steven Tjoe, “The Unintended Consequences of Patent ‘Reform,’” CPIP Blog (April 4, 2014)
- Steven Tjoe, “An Insightful Analysis of ‘Fair and Reasonable’ in the Determination of FRAND Terms,” CPIP Blog (April 3, 2014)
- Steven Tjoe, “Taking a Whack at the DMCA: The Problem of Continuous Re-Posting,” CPIP Blog (March 14, 2014)
- Mark Schultz, “Time to Revise the DMCA: The Most Antiquated Part of the Copyright May Be One of the Newest,” TechPolicyDaily (March 13, 2014)
- Mark Schultz, “A Free Market Perspective on Intellectual Property Rights,” TechPolicyDaily (February 24, 2014)
- Steven Tjoe, “Two More Reasons to Think Twice Before Changing Our Patent System,” CPIP Blog (January 17, 2014)
2013 Essays & Op-Eds
- Adam Mossoff & Mark Schultz, “Congress is Weakening Patents and Threatening to Kill the Innovation Economy,” The Hill (December 9, 2013)
- Matthew Barblan, “Copyright is Still Essential to a Free Market in Creative Works,” CPIP Blog (November 14, 2013)
- Mark Schultz, “Mercatus’s Unhelpful Business Advice to the Creative Industries,” CPIP Blog (October 18, 2013)
- Wayne Sobon, “Guest Post by Wayne Sobon: A Line in the Sand on the Calls for New Patent Legislation,” CPIP Blog (June 24, 2013)
- Chris Holman, “A Critique of a Recent Article Which Found That Sequence Patents Cover the Entire Human Genome,” Holman’s Biotech IP Blog (April 5, 2013)
- Chris Newman, “Summary of Kirtsaeng v. John Wiley & Sons by Professor Chris Newman,” CPIP Blog (March 21, 2013)
- Mark Schultz, “Copyright Reform Through Private Ordering,” CATO Unbound (January 14, 2013)
2012 Essays & Op-Eds
- Mark Schultz, “Copyright, Economic Freedom and the RSC Policy Brief,” CPIP Blog (November 20, 2012)